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Abstract
Objectives: To determine 1) HIV testing practices in a 1400-bed university hospital where local HIV prevalence is 0.4% and 2)
the effect on testing practices of national HIV testing guidelines, revised in March 2010, recommending Physician-Initiated
Counselling and Testing (PICT).
Methods: Using 2 hospital databases, we determined the number of HIV tests performed by selected clinical services, and
the number of patients tested as a percentage of the number seen per service (‘testing rate’). To explore the effect of the
revised national guidelines, we examined testing rates for two years pre- and two years post-PICT guideline publication.
Results: Combining the clinical services, 253,178 patients were seen and 9,183 tests were performed (of which 80 tested
positive, 0.9%) in the four-year study period. The emergency department (ED) performed the second highest number of
tests, but had the lowest testing rates (0.9–1.1%). Of inpatient services, neurology and psychiatry had higher testing rates
than internal medicine (19.7% and 9.6% versus 8%, respectively). There was no significant increase in testing rates, either
globally or in the majority of the clinical services examined, and no increase in new HIV diagnoses post-PICT
recommendations.
Conclusions: Using a simple two-database tool, we observe no global improvement in HIV testing rates in our hospital
following new national guidelines but do identify services where testing practices merit improvement. This study may show
the limit of PICT strategies based on physician risk assessment, compared to the opt-out approach.
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Introduction
In Switzerland, it is estimated that 18,000 (13,000 - 24,000)
adults are living with HIV [1] of whom a substantial proportion
are unaware of their status. The rate of late presentation of HIV
(defined as patients with CD4 counts ,200 cells/mL at diagnosis)
remains high, at around 30% [2]. Risk factors for late diagnosis in
Switzerland include older age, being married, having children,
being heterosexual and, in women, not being pregnant [2]. Late
diagnosis is associated with increased morbidity and mortality
[3,4] and increased healthcare costs [5], while HIV-infected
individuals unaware of their status do not modify risk behaviour to
avoid onward transmission [6].
Having a low threshold for HIV testing is key in identifying
patients early in the course of infection. In 2006, the Centers for
Disease Control and Prevention (CDC) published revised guide-
lines on HIV testing which recommend standardised, non-targeted
‘opt-out’ HIV testing for adolescents and adults aged 13 to 64
years in all health care settings, where the prevalence of
undiagnosed HIV infection is $0.1% [7,8]. In Switzerland, as
elsewhere in Europe, ‘opt-out’ testing has not been adopted.
However, in response to accumulating evidence for links between
HIV infection and certain risk groups and non-infectious diseases,
the Swiss Federal Office of Public Health published revised
national testing guidelines in March 2010 recommending Physi-
cian-Initiated Counselling and Testing (PICT) [9]. These guide-
lines maintain the need for prevention counselling and verbal
patient consent, and promote testing in four broad clinical settings:
1) symptoms or signs of acute HIV infection (AHI); 2) when HIV
enters into the differential diagnoses, such as in sexually trans-
mitted infections, neurological syndromes (dementia, viral menin-
gitis, encephalitis, myelopathy, facial palsy, polyneuropathy) and
AIDS-defining illnesses, or when screening is required, as for
pregnant women and blood and organ donors; 3) individuals with
high risk behaviour and 4) occlusive vascular events (myocardial
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should be based on risk behaviour assessment [9].
To examine the impact of these revised guidelines on HIV
testing practices, we conducted a retrospective analysis of testing
practices in different clinical services before (2008–2009) and after
(2010–2011) guideline publication. The study took place in our
1400-bed university hospital whose catchment area has an HIV
prevalence of 0.4% [1].
Methods
Ethics Statement
In accordance with Public Health Legislation of the Canton of
Vaud, no ethical approval was required for this study as it was
based on two retrospective anonymised databases [10,11].
Furthermore, our hospital has the authority to employ the General
Waiver of the Federal Committee of Experts on Professional
Confidentiality in Medical Research and use anonymised data
without patient consent and without formal ethical approval, on
condition that all patients receive information regarding research
activity led by the hospital. The patients may refuse access to their
data and this is documented in the administrative system [12,13].
Sample Selection
We examined data from the following clinical services: medical
outpatients (OP) (comprising three non-specialist clinics: one for
minor injuries, one which operates as a public general practice
centre by appointment, and one drop-in clinic where no
appointment is required); general internal medicine inpatients
(IP); neurology IP; cardiology IP (including patients presenting
with acute coronary syndromes); intensive care units (ICU);
emergency departments (ED, including the acute admission unit);
psychiatry IP (excluding services for substance misuse where HIV
testing is practised routinely); oncology OP (treating patients with
solid organ tumours and lymphoma) and surgery IP (comprising
vascular, cardiothoracic, maxillofacial, ear, nose and throat,
gastrointestinal, urological and neuro- surgery).
The clinical services were chosen for the following reasons: 1) to
examine services dealing with pathologies specifically mentioned
in the updated national guidelines (neurological and cardiovascu-
lar disease); 2) to examine clinical services recently highlighted in
the literature (ICU [14], ED [8,15] and oncology [16]) and 3) to
examine services whose patients have longer hospital stays, a factor
previously shown to affect testing practices [15] (internal medicine,
psychiatry). All the services examined organise regular intra-
service academic and junior staff training activities that are
standard in a university hospital; our infectious diseases service
provided no specific training in HIV testing as part of this study.
In order to focus on the HIV testing practices in non-specialists
in HIV medicine, we did not include the infectious diseases
service. We also excluded services where HIV testing is part of
specialty protocol: antenatal and reproductive medicine, blood
transfusion, transplant medicine and dialysis services (routine HIV
screening) and occupational health medicine (screening for HIV
and other blood-borne viruses in the context of exposure to
biological fluids). To limit our study to testing in adults, as defined
by our hospital policy, we excluded individuals aged #15 years.
Finally, to examine doctor-initiated as opposed to patient-initiated
HIV testing, we excluded samples obtained through voluntary
anonymous testing.
HIV Test Requests and Calculation of HIV Testing Rate
All serum samples for HIV testing in our hospital are coded
according to the clinical service from which they are sent. HIV
testing is performed in the service of immunology and allergy using
a fourth generation HIV screening assay which identifies anti-
HIV1 and anti-HIV2 antibodies (IgG and IgM) and the p24
antigen (Cobas Elecsys HIV combi PT, Roche Diagnostics).
Reactive samples undergo confirmatory tests (neutralisation assay
for the p24 antigen (Cobas Elecsys HIV Ag Confirmatory Test,
Roche Diagnostics) and a line immunoassay (INNO-LIA
TM HIV
I/II Score, Innogenetics NV) as well as plasma viral load
determination on a second sample (Cobas AmpliPrep/Cobas
TaqMan HIV-1, version 2.0, limit of detection at 20 copies/ml,
Roche Diagnostics) before they are released as positive for HIV.
Using the service of immunology and allergy database
(‘Database 19), we obtained the number of HIV tests requested
by each of the clinical services we wished to examine and the
number of samples testing positive. Positive tests were categorised
as AHI, new positives (non-acute), known positives (in patients
diagnosed previously) and false positives. Only AHI episodes and
new positives were used in our analyses. To determine the effect of
the revised national HIV testing guidelines published in March
2010, we examined the number of tests performed throughout
2010 and then up to 31
st December 2011 to allow for a possible lag
period between the guidelines publication and their integration
into clinical practice. To compare testing practices pre- and post-
guideline publication we collected data from four twelve-month
time periods: 1
st January to 31
st December 2008 and 2009 (pre-
guidelines) and 1
st January to 31
st December 2010 and 2011 (post-
guidelines).
In addition to the absolute number of HIV tests requested by
each clinical service, we also determined the number of tests
performed as a function of the number of patients seen (‘HIV
testing rate’), a better measure of testing practices than the
absolute number of tests performed that also accounts for any
changes in patient turnover observed with time. We obtained
figures for patient turnover during the same four twelve-month
periods (2008 to 2011) from the central hospital database
(‘Database 2’). We examined the number of patients seen, rather
than the number of patient episodes, based on the observation that
many of the OP services will see a single patient more than once,
thereby potentially falsely reducing testing rates in OP compared
to IP services.
After ensuring that each patient tested was tested only once in
each twelve-month period studied, we expressed HIV testing rate
for each clinical service as a percentage using the following
equation:
(No. of HIV tests performed in 12-month period/No. of patients
seen during the same period) x 100.
Using Database 2, we also obtained figures for median duration
of stay (MDOS) among hospital IP, and mean age for all patients.
Statistical Analyses
Descriptive analyses used means with standard deviation or
medians with interquartile range. Categorical data were assessed
in two-way contingency table analyses using the Chi squared test.
Continuous data were analysed using Student’s t-test and Spear-
man’s rank correlation coefficient. All statistical analyses were
performed using STATA version 11 (Stata Corporation, College
Station, TX, USA) and Microsoft Excel 2008 (Microsoft
Corporation, Redmond, WA, USA).
Results
Patient Turnover
Combining the clinical services examined, a total of 253,178
patients were seen between 1
st January 2008 and 31
st December
HIV Testing in Switzerland
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were seen in the ED (Figure 1). The total number of patients seen
increased progressively from 2008 to 2011; increases were
observed specifically in the ED, psychiatry, oncology and internal
medicine services, whilst numbers in the other services remained
static or declined with time (Figure 1).
Number of Tests Performed per Twelve-month Period
Combining the clinical services, a total of 9,183 tests were
performed, with numbers increasing with time (Figure 2A). By far
the greatest number of tests were performed in medical OP
(Figure 2A), accounting for 36.5–37.8% of all tests performed.
After the ED, the other services performed similar numbers of
tests, with oncology OP performing the smallest number
(Figure 2A). Of all tests performed, 80 were positive (0.9%).
Number of Tests Performed per Number of Patients Seen
(HIV Testing Rate)
Examining HIV testing rates, medical OP had the highest rates,
followed by neurology IP (Figure 2B). Although the ED had the
second highest number of HIV tests performed, the HIV testing
rates were the lowest of all services examined (Figure 2B). Of
interest, psychiatry IP had higher testing rates than internal
medicine IP, cardiology IP and oncology OP (Figure 2B).
Effect of Revised National Guidelines on HIV Testing
We compared HIV testing rates from year to year and between
the two two-year periods pre- and post-PICT guidelines.
Examining all services together, we observed no significant
difference in HIV testing rates with time (P=0.94). Examining
the subspecialties highlighted in the revised testing guidelines
relating to cardiovascular and neurological pathologies, cardio-
thoracic and vascular surgery had higher testing rates than those of
surgery IP as a whole (5% compared to 2.1%, in 2008) but these
rates fell in 2010 and 2011; the neurology IP service had high
testing rates pre-guidelines (19.7% in 2008) and these remained
high but did not increase significantly in 2010 and 2011. Although
there was a small increase in testing rates in the cardiology IP
service, this was not significant (P=0.7).
In contrast to the other clinical services, the ED testing rates
increased from 0.9% to 1.1% between 2008 and 2011. Although
the increase from year to year was not significant, the rate
throughout 2010 and 2011 (post-PICT guidelines) was significant-
ly higher than that throughout 2008 and 2009 (P=0.011).
Rate of Samples Testing Positive Among Patients Tested
The percentage of new HIV diagnoses among patients tested for
HIV fell from 1.1% (mean; SD 0.2%) pre-PICT guidelines to
0.7% (mean; SD 0.1%) post-guidelines (P=0.3). Of new HIV
diagnoses, the percentage of cases of AHI remained static at 8.5–
9.4% pre- and post-guidelines. The percentages of positive tests
per number of tests performed in each clinical service are shown in
Table 1.
Effect of MDOS and Age on Testing
Of the inpatient services, psychiatry IP had the longest MDOS
and ED patients had the shortest (Table 1). Examining all
inpatient services together, we did not observe a significant
correlation between MDOS and testing rates in either period
studied (P=0.27). In all clinical services, the mean age of patients
tested was lower than that of all patients seen (Table 1). The
difference was most marked in the ED where the mean difference
between the ages of patients seen and those tested throughout the
study period was of the order of 20 years (Table 1).
Figure 1. Numbers of patients seen in each clinical service during the four twelve-month periods studied. Abbreviations: OP,
outpatients; IP, inpatients; ICU, intensive care units; ED, emergency departments.
doi:10.1371/journal.pone.0039299.g001
HIV Testing in Switzerland
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39299Discussion
Using two hospital databases, we have compared HIV testing
rates between different clinical services before and after the
publication of revised national testing guidelines. Our data are
centre-specific and as such can be interpreted within the
framework of our hospital and the organisation of each clinical
service.
The relatively high testing rates among neurology IP may be
explained by the strong links this service has had with our
infectious diseases service since 2006 [17]. Patients with neuro-
logical syndromes described in the 2010 guidelines (see in-
troduction) were already being HIV tested by our colleagues
prior to 2010, possibly explaining similar testing rates before and
after guideline revision. In contrast, the relatively low testing rates
among oncology OP are surprising as this service treats lymphoma
patients as well as patients with solid-organ cancers. Although
solid-organ malignancies are not specifically mentioned in the
latest guidelines, there is accumulating evidence that HIV
increases the risk of certain such cancers [16,18]. We can explain
the low testing rates by the fact that our hospital is a tertiary
referral centre, and that many patients with lymphoma are HIV
tested pre-transfer and so would not be tested by our oncology
service (S.P., personal communication). However, as one British
centre observed that 41% of their lymphoma patients were not
HIV tested [19], the testing practices in our oncology service are
now part of a collaborative study. Finally, the observation of
testing in predominantly younger patients across all clinical
services suggests a global belief that HIV is a young person’s
disease. This goes against recently reported changes in HIV
epidemiology, namely the increasing HIV prevalence in older
individuals [4,20,21], and suggests that HIV testing competency,
even in the better performing services, should be reviewed.
The ED, with the lowest testing rates of all services studied,
merit particular consideration. A recent review of ED HIV testing
practices placed the median proportion of eligible patients being
tested at 22% (range 7–69%) [22]. One study specifically
examining the PICT approach observed lower rates at 2.1–2.5%
of eligible patients [23]. Of the 0.9–1.1% patients tested in our
own ED, we do not have figures on how many patients were
‘eligible’ for testing (see below), but this testing rate, despite the
small increase with time, is certainly low compared to the other
services we studied. Why are ED testing rates so low? Short
duration of stay has previously been cited as an explanation for
poor testing rates [15] and certainly the MDOS of patients in our
ED was the lowest of all IP services studied. However, that higher
testing rates were observed in medical OP compared to all IP
services suggests that the length of patient contact is not so critical;
perhaps the opportunity for privacy and confidentiality is more
important than the time spent with each patient [24]. Perhaps
beliefs that HIV risk factors ‘do not relate’ to the primary role of
the ED play a role [24,25]. Whatever the reason(s), as previous
studies have shown that measures to optimise ED testing rates
produce modest if any improvement [8,15], we can propose two
approaches to optimise testing in patients who pass through this
service. The first would be the introduction of rapid testing [26] so
that patients can receive their test results in the ED during the shift
of the doctor offering the HIV test. The second, more pragmatic,
approach would be to focus on improving testing in patients
beyond their time in the ED, either in OP follow-up (in our centre,
this would be in the medical OP service) or when they are
admitted to other IP services.
This study has several limitations. We did not collect data on the
presenting complaints of patients tested compared to all the
patients seen in each service and so cannot identify testing rates
among ‘eligible’ as opposed to all patients seen. Although our
testing rates were calculated from patient turnover per annum,w e
did not examine the timing of junior staff turnover, or the use of
shift systems within each service, factors which may affect testing
Figure 2. HIV testing practices by clinical service and year. Figure shows the numbers of tests performed (A) and the testing rates (B) in each
clinical service during each of the four twelve-month periods studied. Abbreviations: OP, outpatients; IP, inpatients; ICU, intensive care units; ED,
emergency departments.
doi:10.1371/journal.pone.0039299.g002
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among the acute clinical services. Another potential bias is that of
patient origin. Two of the three medical OP clinics we examined
receive a high proportion of migrants or political refugees from
countries with high HIV prevalence (up to 65% of outpatient
episodes, P.B., personal communication), potentially lowering the
threshold for HIV testing compared to other clinical services. We
do not have figures for migrants attending the other clinical
services but, examining country of origin data from Database 2,
we can estimate the percentages to be much lower than 65%.
Finally, the design of our study does not enable us to identify
where the difficulty lies in adopting new guidelines: whether the
heads of each service are not aware of them, do not agree with
them or have practical difficulties in adhering to them [27].
Determining the barriers to testing will be the subject of further
work in the services we have identified with low testing rates.
To summarise, to our knowledge, this is the first study
comparing testing rates between different clinical services using
the two-database tool we describe. Although our data are centre-
specific, our methods for obtaining these data are applicable to any
hospital with the appropriate databases. These methods allow
under-testing services to be identified and targeted so that missed
opportunities for testing, and the associated costs of late HIV
diagnosis, may be minimised.
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